Other Medical Devices - Central Africa

  • Central Africa
  • The projected revenue in the Other Medical Devices market market in Central Africa is expected to reach US$118.20m in 2024.
  • This represents a significant market potential for the country in this market.
  • Looking ahead, the revenue is anticipated to exhibit a compound annual growth rate (CAGR 2024-2029) of 4.77%, resulting in a market volume of US$149.20m by 2029.
  • This growth indicates a positive trajectory for the market in Central Africa, presenting opportunities for both domestic and international players in the industry.
  • In comparison to other countries, the United States is forecasted to generate the highest revenue in the global market, with an estimated amount of US$72,780.00m in 2024.
  • This highlights the dominance of the United States in the global landscape of the Other Medical Devices market market.
  • Central Africa has seen an increased demand for innovative and affordable medical devices to address the region's healthcare challenges.

Key regions: United Kingdom, China, Netherlands, Europe, Italy

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other Medical Devices market in Central Africa is experiencing steady growth due to various factors. Customer preferences in the region are driving the demand for Other Medical Devices. Central African customers are increasingly seeking innovative and advanced medical devices that can improve healthcare outcomes. They are looking for devices that are reliable, easy to use, and cost-effective. Additionally, there is a growing awareness about the importance of preventive healthcare, which has led to an increased demand for devices that can aid in early detection and diagnosis of medical conditions. Trends in the market indicate a shift towards more technologically advanced and portable medical devices. Central African countries are investing in healthcare infrastructure and upgrading their healthcare systems, which is driving the demand for modern medical devices. The market is witnessing a rise in the adoption of digital health technologies, such as telemedicine and remote patient monitoring, which require the use of Other Medical Devices. There is also a growing demand for portable devices that can be used in remote areas with limited access to healthcare facilities. Local special circumstances in Central Africa also contribute to the development of the Other Medical Devices market. The region has a high burden of communicable diseases, such as malaria and HIV/AIDS, which require the use of diagnostic devices. Central African countries are also facing an increasing prevalence of non-communicable diseases, such as diabetes and cardiovascular diseases, which require monitoring and treatment devices. These factors are driving the demand for a wide range of Other Medical Devices in the region. Underlying macroeconomic factors, such as population growth and urbanization, are also influencing the development of the Other Medical Devices market in Central Africa. The region has a rapidly growing population, which is increasing the demand for healthcare services and medical devices. Urbanization is leading to lifestyle changes and an increase in chronic diseases, which further drives the demand for medical devices. Additionally, Central African countries are investing in healthcare infrastructure and increasing healthcare spending, which creates a favorable environment for the growth of the Other Medical Devices market. In conclusion, the Other Medical Devices market in Central Africa is developing due to customer preferences for innovative and advanced devices, trends towards technologically advanced and portable devices, local special circumstances such as high disease burden, and underlying macroeconomic factors such as population growth and urbanization. These factors are driving the demand for a wide range of Other Medical Devices in the region.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)